Brain dysfunction in fibromyalgia and somatization disorder using proton magnetic resonance spectroscopy: a...

Area of Science:

• Neuroscience
• Medical Imaging
• Psychiatry

Background:

• Fibromyalgia (FM) and somatization disorder (STD) are complex conditions with unclear underlying neurobiological mechanisms.
• Understanding brain metabolite alterations may provide insights into the pathophysiology of these disorders.

Purpose of the Study:

• To investigate brain metabolite patterns in patients with FM and STD using magnetic resonance spectroscopy (MRS).
• To correlate observed metabolite patterns with psychological variables such as pain catastrophizing, anxiety, depression, and quality of life.

Main Methods:

• A controlled, cross-sectional study involving patients with FM and STD recruited from primary care.
• Utilized Magnetic Resonance Imaging (MRI) and magnetic resonance spectroscopy (MRS) to analyze brain metabolites.
• Administered questionnaires assessing pain, psychological distress, and quality of life.

Main Results:

• Significantly increased glutamate + glutamine (Glx) levels were observed in the posterior cingulate cortex (PCC) of FM and STD patients compared to healthy controls (P = 0.043).
• A positive correlation was found between Glx levels in the PCC and pain catastrophizing in the combined FM + STD group (r = 0.397; P = 0.033).
• A negative correlation was identified between quality of life and the myo-inositol/creatine ratio in the left hippocampus (r = -0.500; P = 0.025).

Conclusions:

• Glutamate plays a significant role in the molecular processes underlying FM and STD.
• Proton magnetic resonance spectroscopy ((1)H-MRS) shows potential for STD diagnosis and research.
• Targeting glutamatergic activity pharmacologically may offer a therapeutic strategy to improve patient outcomes.